SCHEMBL22769372

SCHEMBL22769372

CCOC(=O)C(C=O)N(C)Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
LMNA P02545 2/20 0.50
POLB P06746 2/20 0.50
HSD17B10 Q99714 1/20 0.50
RAB9A P51151 4/20 0.45
NPC1 O15118 3/20 0.45
HTT P42858 1/20 0.44
MMP8 P22894 1/20 0.43
KMT2A Q03164 4/20 0.43
MEN1 O00255 3/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
PIN1 Q13526 1/20 0.42
ADRA2B P18089 1/20 0.41
ADRA2C P18825 1/20 0.41
SLC6A2 P23975 1/20 0.41
HTR2A P28223 1/20 0.41
SLC6A4 P31645 1/20 0.41
ADRA1A P35348 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14786664 0.81 ALDH1A1 (0.55) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL21258291 0.80 MEN1 (0.55) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL11015731 0.80 MEN1 (0.55) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL25205668 0.79 L3MBTL1 (0.52) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL22963922 0.79 ADRA2B (0.44) ALDH1A1LMNARAB9ANPC1KMT2A
SCHEMBL26415297 0.79 ALDH1A1 (0.52) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL4927817 0.78 ALDH1A1 (0.51) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL8316510 0.77 ALDH1A1 (0.50) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL7412667 0.77 ALDH1A1 (0.50) ALDH1A1L3MBTL1LMNAPOLBHSD17B10
SCHEMBL27475763 0.76 L3MBTL1 (0.60) ALDH1A1L3MBTL1LMNAPOLBHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11498909-B2 Compound acting as antibiotics KBP BIOSCIENCES CO., LTD. (CN) 2022-11-15 US disclosed
US-20200392096-A1 COMPOUND ACTING AS ANTIBIOTICS KBP BIOSCIENCES CO., LTD. (CN) 2020-12-17 US disclosed
EP-3750881-A1 COMPOUND ACTING AS ANTIBIOTICS KBP Biosciences Co., Ltd. (CN) 2020-12-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11498909-B2 Compound acting as antibiotics PEPD, NRDC, DPP4 ALDH1A1 1492/4885L3MBTL1 2656/4885LMNA 3773/4885
US-20200392096-A1 COMPOUND ACTING AS ANTIBIOTICS PEPD, NRDC, DPP4 ALDH1A1 1492/4885L3MBTL1 2656/4885LMNA 3773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.